AC Immune SA (ACIU)
2.66
-0.17
(-6.01%)
USD |
NASDAQ |
Sep 24, 16:00
2.695
+0.04
(+1.32%)
Pre-Market: 19:59
AC Immune Cash and Short Term Investments (Quarterly) : 93.42M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.42M |
| March 31, 2026 | 93.08M |
| December 31, 2025 | 115.38M |
| September 30, 2025 | 136.33M |
| June 30, 2025 | 159.72M |
| March 31, 2025 | 164.58M |
| December 31, 2024 | 182.61M |
| September 30, 2024 | 187.18M |
| June 30, 2024 | 194.89M |
| March 31, 2024 | 116.38M |
| December 31, 2023 | 122.44M |
| September 30, 2023 | 87.37M |
| June 30, 2023 | 103.96M |
| March 31, 2023 | 115.41M |
| December 31, 2022 | 132.50M |
| September 30, 2022 | 142.75M |
| June 30, 2022 | 161.01M |
| March 31, 2022 | 188.90M |
| December 31, 2021 | 217.54M |
| September 30, 2021 | 202.16M |
| June 30, 2021 | 215.43M |
| March 31, 2021 | 229.60M |
| December 31, 2020 | 255.55M |
| Date | Value |
|---|---|
| September 30, 2020 | 268.37M |
| June 30, 2020 | 276.99M |
| March 31, 2020 | 287.18M |
| December 31, 2019 | 298.02M |
| September 30, 2019 | 303.32M |
| June 30, 2019 | 293.06M |
| March 31, 2019 | 303.38M |
| December 31, 2018 | 189.15M |
| September 30, 2018 | 203.85M |
| June 30, 2018 | 103.39M |
| March 31, 2018 | 114.52M |
| December 31, 2017 | 127.63M |
| September 30, 2017 | 121.13M |
| June 30, 2017 | 129.67M |
| March 31, 2017 | 137.95M |
| December 31, 2016 | 149.76M |
| September 30, 2016 | 162.57M |
| June 30, 2016 | 84.56M |
| March 31, 2016 | 70.86M |
| December 31, 2015 | 76.45M |
| September 30, 2015 | 54.94M |
| June 30, 2015 | 20.71M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Precigen, Inc. | 38.21M |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| Aldeyra Therapeutics, Inc. | 45.09M |
| BeOne Medicines Ltd. | 5.259B |